Evidence map›Paper›PMID 19450716›Full record

ArticleBone2009

Parathyroid hormone suppresses osteoblast apoptosis by augmenting DNA repair.

Matthew Schnoke, Sharon B Midura, Ronald J Midura

Abstract read
In one paragraph

Article in Bone, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. The pathophysiology of immunoporosis: innovative therapeutic targets.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2021
    Review
  6. Article
  7. Skeletal Aging and Osteoporosis: Mechanisms and Therapeutics.International journal of molecular sciences · 2021
    Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Intermittent PTH administration and mechanical loading are anabolic for periprosthetic cancellous bone.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2015
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Matthew SchnokeDepartment of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, USA.
Sharon B Midura
Ronald J Midura
Cleveland Clinic Lerner College of Medicine · US

Funding

Robotics CoreP30AR050953 · NIAMS · CLEVELAND CLINIC LERNER COM-CWRU · PI HASCALL, VINCENT CHARLES · 2004 to 2008
$2.9M
MINERALIZATION OF PRIMARY BONER01AR052775 · NIAMS · UNIVERSITY OF MISSOURI KANSAS CITY · PI GORSKI, JEFFREY PAUL · 2005 to 2008
$1.1M
MECHANISM FOR BONE SIALOPROTEIN TO NUCLEATE BIOAPATITER01AR045171 · NIAMS · CLEVELAND CLINIC FOUNDATION · PI MIDURA, RONALD JOSEPH · 1999 to 2002
$539k
NIAMS NIH HHS AR045171NIAMS NIH HHS P30 AR050953NIAMS NIH HHS R01 AR045171NIAMS NIH HHS R01 AR052775
6 · The paper itself

Abstract

Daily injection of parathyroid hormone (PTH) is a clinically approved treatment for osteoporosis. It suppresses apoptosis of bone-forming osteoblasts although its exact anti-apoptotic mechanism(s) is incompletely understood. In this study, PTH treatment of cultured osteoblasts blocked the pro-apoptotic effects of serum withdrawal and nutrient deprivation; hydrogen peroxide induced oxidative stress, and UV irradiation. We hypothesized that PTH might suppress osteoblast apoptosis by enhancing DNA repair. Evidence is provided showing that post-confluent, non-proliferating osteoblasts treated with PTH exhibited a protein kinase A-mediated activation of two proteins that regulate DNA repair processes (proliferating cell nuclear antigen and forkhead box transcription factor 3a) as well as a suppression of the pro-apoptotic growth arrest and DNA damage protein 153. Additional proof of a connection between DNA damage and osteoblast apoptosis came from an unexpected finding whereby a majority of fixed PTH-treated osteoblasts scored weakly positive for Terminal Deoxynucleotidyl dUTP Nick-End Labeling (TUNEL), even though similar cultures were determined to be viable via a trypsin replating strategy. TUNEL identifies DNA excision repair, not just apoptotic DNA fragmentation, and the most likely explanation of these TUNEL results is that PTH's activation of DNA repair processes would permit nucleotide incorporation as a result of enhanced excision repair. This explanation was confirmed by an enhanced incorporation of bromodeoxyuridine in PTH-treated cells even though a majority of the cell population was determined to be non-replicating. An augmentation of DNA repair by PTH is an unreported finding, and provides an additional explanation for its anti-apoptotic mechanism(s).

Indexed as

ApoptosisCells, CulturedDNA FragmentationDNA RepairForkhead Box Protein O3Forkhead Transcription FactorsHumansHydrogen PeroxideIn Situ Nick-End LabelingOsteoblastsOsteogenesisOxidative StressParathyroid HormoneProliferating Cell Nuclear AntigenTranscription Factor CHOPUltraviolet RaysDDIT3 protein, humanForkhead Box Protein O3Forkhead Transcription FactorsFOXO3 protein, humanHydrogen PeroxideParathyroid HormoneProliferating Cell Nuclear AntigenTranscription Factor CHOP

Identifiers

PMID19450716
PMCPMC2752836
OpenAlexW1968149664

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.